CompletedNot Applicable

A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis

1,323 participantsStarted 2010-01-01

Plain-language summary

Stenosis of the renal graft arteries occurs in 1 to 26% of cases and can damage the graft. Endovascular treatment is first-line treatment. The main objective of this study is to identify the predictive factors of failure of peri-anastomotic.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients who had a renal transplant from brain-dead donors or from living donors * All patients who had a Transplant Renal Artery Stenosis Exclusion Criteria: * None

What they're measuring

The technical success rate of endovascular treatment

Timeframe: 30 days

Trial details

NCT IDNCT03477071

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-01-01

View on ClinicalTrials.gov More Unrecognized Condition trials